{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12166031", "DateCompleted": {"Year": "2002", "Month": "09", "Day": "27"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0738-0658", "JournalIssue": {"Volume": "21", "Issue": "2", "PubDate": {"Year": "2002", "Month": "Jun"}}, "Title": "Puerto Rico health sciences journal", "ISOAbbreviation": "P R Health Sci J"}, "ArticleTitle": "Natural product drug discovery and development: the United States National Cancer Institute role.", "Pagination": {"StartPage": "97", "EndPage": "111", "MedlinePgn": "97-111"}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick Cancer Research and Development Center, Fairview Center, Suite 206, P. O. Box B, Frederick, MD 21702-1201, USA."}], "Identifier": [], "LastName": "Cragg", "ForeName": "Gordon M", "Initials": "GM"}], "PublicationTypeList": ["Address", "Historical Article"]}, "MedlineJournalInfo": {"Country": "Puerto Rico", "MedlineTA": "P R Health Sci J", "NlmUniqueID": "8303541", "ISSNLinking": "0738-0658"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-HIV Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Factors"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification"], "DescriptorName": "Anti-HIV Agents"}, {"QualifierName": ["history", "isolation & purification", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["history", "isolation & purification"], "DescriptorName": "Biological Factors"}, {"QualifierName": [], "DescriptorName": "Cooperative Behavior"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": ["economics", "methods"], "DescriptorName": "Drug Evaluation"}, {"QualifierName": ["economics", "methods"], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "History, 20th Century"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "International Cooperation"}, {"QualifierName": ["history"], "DescriptorName": "National Institutes of Health (U.S.)"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "United States"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "8", "Day": "9", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "9", "Day": "28", "Hour": "4", "Minute": "0"}, {"Year": "2002", "Month": "8", "Day": "9", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12166031"]}}], "PubmedBookArticle": []}